|
On April 25, 2023, the U.S. Food and Drug Administration’s (FDA’s) Division of Drug Information will hold a webinar entitled “FDA Drug Topics: Rare Diseases - Challenges and Progress in Drug Development.” The development of drugs to treat rare diseases is challenging on multiple levels. This webinar will examine these challenges and FDA programs to drive scientific and regulatory innovation and engagement to accelerate the availability of treatments for patients with rare diseases.
The learning objectives for this webinar are:
- Describe the challenges involved in developing a drug for a rare disease.
- Identify key aspects of the FDA regulatory framework that are relevant to rare disease drug development.
- Summarize the efforts of the FDA Center for Drug Evaluation and Research to accelerate rare disease drug development through innovation and engagement.
Date/Time of the Webinar:
Date: April 25, 2023
Time: 1:00 p.m. – 2:00 p.m. ET
Registration is complimentary; however, registration is required by clicking here. This activity is intended for physicians, physician assistants, nurses, pharmacists, pharmacy technicians, certified public health professionals, other health care professionals, and students.
FDA’s Division of Drug Information is presenting a series of continuing education (CE) webinars targeting the needs of health care professionals. This series of educational webinars is designed to aid physicians, physician assistants, nurses, pharmacists, pharmacy technicians, certified public health professionals, other health care professionals, and students, to provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety. The objectives of this webinar series are to explain how to utilize FDA’s drug information, medication safety resources, and regulatory guidance, to improve delivery of patient care and optimize outcomes, and describe and inform health care providers of recent labeling changes which would impact prescribing and medication management to optimize patient care. Click here to learn more about FDA Division of Drug Information Webinars.
|
